96 related articles for article (PubMed ID: 7519907)
21. Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate.
Ricciardelli C; Horsfall DJ; Skinner JM; Henderson DW; Marshall VR; Tilley WD
In Vitro Cell Dev Biol; 1989 Nov; 25(11):1016-24. PubMed ID: 2592295
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
23. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
[TBL] [Abstract][Full Text] [Related]
24. [Benign prostatic hyperplasia: a stromal disease].
Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
Urologe A; 1989 Nov; 28(6):321-8. PubMed ID: 2481358
[TBL] [Abstract][Full Text] [Related]
25. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property.
Lin VK; Wang SY; Vazquez DV; C Xu C; Zhang S; Tang L
Prostate; 2007 Sep; 67(12):1265-76. PubMed ID: 17597114
[TBL] [Abstract][Full Text] [Related]
26. Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle.
Shapiro E; Hartanto V; Lepor H
Prostate; 1992; 20(4):259-67. PubMed ID: 1376909
[TBL] [Abstract][Full Text] [Related]
27. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
28. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
29. Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate.
Cardoso LE; Falcão PG; Sampaio FJ
BJU Int; 2004 Mar; 93(4):532-8. PubMed ID: 15008724
[TBL] [Abstract][Full Text] [Related]
30. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
Fibbi B; Morelli A; Vignozzi L; Filippi S; Chavalmane A; De Vita G; Marini M; Gacci M; Vannelli GB; Sandner P; Maggi M
J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
[TBL] [Abstract][Full Text] [Related]
31. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
[TBL] [Abstract][Full Text] [Related]
32. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
[TBL] [Abstract][Full Text] [Related]
33. Morphological features and kinetics of primary cultures of BPH tissue supported by TV1 medium.
De Angeli S; Valenti F; Buoro S; Conconi MT; Parnigotto PP
Ann Anat; 1996 Jan; 178(1):41-8. PubMed ID: 8717326
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.
Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z
Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436
[TBL] [Abstract][Full Text] [Related]
35. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
36. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
Bartsch G; Frick J; Rüegg I; Bucher M; Holliger O; Oberholzer M; Rohr HP
J Urol; 1979 Oct; 122(4):481-6. PubMed ID: 90176
[TBL] [Abstract][Full Text] [Related]
37. Pathology of benign prostatic hyperplasia.
Foster CS
Prostate Suppl; 2000; 9():4-14. PubMed ID: 11056496
[No Abstract] [Full Text] [Related]
38. Rho kinase activation mediates adrenergic and cholinergic smooth muscle contractile responses in the mouse prostate gland.
White CW; Short JL; Ventura S
Eur J Pharmacol; 2013 Dec; 721(1-3):313-21. PubMed ID: 24055190
[TBL] [Abstract][Full Text] [Related]
39. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
